Titan Medical Inc (TMDIF)

[66Mustang]

It may be premature to declare "McNally is our hero" but many of us believe it will become a valid statement.

As for JnJ, that just further shows the difficulty in getting to the point that Titan is now at. JnJ can take a one quarter charge of $900M because of a 2 year delay. When a one year Hugo delay was announced (in late 2019? Early 2020?) that was further evidence.

For JnJ this 2 year delay puts them at least 3 years away from the marketing of their system. Great opportunity for MDT to push Hugo globally before a huge competitor like JnJ can dig in. But it also increases Titan's inherent value by virtue of their relative proximity to marketability. Meaning whoever wants to pony up a few billy can have a/another product offering sooner than JnJ's Ottava.

So, possibilities include...
1) JnJ could snag us, beat their Ottava to market and starts collecting revenue/foot in the door of the marketplace before MDT gets too far ahead.
2)MDT can snag us quickly, finish Enos to their liking and get a second product on the market before big competitor JnJ gets Ottava to market.
3) ISRG could snag us and keep both JnJ and MDT from building too much robotic strength for the next couple years.
4) Anyone else can jump in out of the blue (maybe Stryker?) and shortcut all the above.